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more children than their counterparts in industrialized countries and view child-rearing as a key life accomplishment. These personal
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assisted reproductive technologies. In this paper, I outline 35 years of assisted reproductive technologies in Israel by tracing a
principal axis in the development of three major technologies of assisted reproduction: the proliferation of IVF-ICSI; the globalization
of gamete donation; and the privatization of surrogacy. The paper is based on a policy analysis as well as various studies of assisted
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Israel is well known as a pronatalist country. Whether due to
the Biblical commandment to ‘be fruitful and multiply’ or the
traumas of the Holocaust and perennial wars, reproduction
has been a central goal in Israel, some would say a
preoccupation, since its foundation. Indeed, Israeli women
bear substantially more children than their counterparts in
industrialized countries (3.03 versus, for example, 2.01 and
1.56 in the USA and Western Europe, respectively; CIA6.05.004
ed by Elsevier Inc. This is an open
/by-nc-nd/4.0/).factbook, 2015a and Eurostat, 2015, respectively) and tend
to view child rearing as ‘life’s greatest joy’ (Glickman, 2003).
By the same token, barrenness often represents the quintes-
sential female suffering, and voluntary childlessness is
strongly condemned (Donath, 2014, 2015). Jewish religious
authorities are equally pronatalist and gladly accommodate
assisted reproductive technologies. Doctors, for their part,
seek to serve the multiparous religious communities and
thus accommodate traditional sensitivities in their practiceaccess article under the CC BY-NC-ND license
17Assisted reproductive technologies in Israel(Ivry, 2010). Demography-related ecological concerns are
completely absent from Israeli reproductive discourses.
Israel’s first ‘IVF baby’, the world’s fifth, was born in 1982,
signalling the dawn of a prosperous assisted reproductive
technology industry: Israeli women undergo, on average, more
IVF cycles than women in any other country. Practically all of
the latest reproductive technologies are available to them:
intracytoplasmic sperm injection (ICSI) has become integral to
IVF; gamete ‘donation’ freezing and banking, as well as embryo
freezing, surrogacy and preimplantation genetic diagnosis, are
all practised legally.Whereas some treatments (e.g. surrogacy)
entail extremely high costs, others (e.g. donor sperm) are
available for relatively affordable sums. A few of these
technologies are largely state subsidized. Sex selection is
tightly regulated but is also allowed under some circumstances,
as is posthumous reproduction. The adjacent field of human
embryonic stem cell research is also booming.
In the following, I outline 35 years of assisted reproductive
technologies in Israel by tracing a principal axis in the
development of three major technologies: the proliferation
of IVF-ICSI; the globalization of gamete donation; and the
privatization of surrogacy. Evidently, all three axes are present
to some degree in the trajectories of each technology. The
paper is based on a policy analysis as well as on additional
studies of assisted reproductive technologies, which I have
conducted in Israel over this period. The latter have all been
conducted in accordance with ethical guidelines and have
received the required ethics approval. The paper’s primary
focus on assisted reproductive technology policies highlights
the state’s role in the shaping of Israel’s assisted reproductive
technology landscape. While the state’s influence appears
to be extremely significant, it is crucial to acknowledge
that Israeli women have been agential in numerous assisted
reproductive technology contexts, ranging from ensuring
religion-compatible practice (Ivry, 2010) to withdrawing from
treatment (Haelyon, 2007) to actively participating in the
formation of the egg donation law (Hashash et al., 2008).Fig. 1 Number of IVF cycles per year in Israel.Proliferation: IVF-ICSI
Fertility treatments have been state funded in Israel since their
establishment. The introduction of IVF by local doctors, in
1981, was welcomed as a ground-breaking addition to the
existing, publicly funded fertility treatments and the birth of
the first local ‘IVF baby’ was celebrated in the media as a
collective national accomplishment, led by saviour local
experts (Birenbaum-Carmeli, 1997, Birenbaum-Carmeli et al.,
2000). In the subsequent two decades, IVF units opened inmost
Israeli hospitals. Politicians, service providers, rabbis, doctors,
feminists and laypersons all praised the innovative technology.
State support for assisted reproductive technologies was
swiftly inscribed into Ministry of Health (MOH) regulations
that entitled every Israeli woman aged 18 to 45, irrespective
of her family status or sexual orientation, to unlimited,
funded treatment up to the birth of two live children with
her current partner, if applicable. Attempts to ration IVF
have all resulted in an outcry from politicians, professionals,
consumers and feminists (Birenbaum-Carmeli, 2004), leaving
the unlimited funding intact. Conservative estimates assess
IVF expenditure, without concomitant costs (e.g. associated
with twin births), at 2% of Israel’s health budget.Maintaining the world’s highest rate of clinics per capita
for some two decades (Collins, 2002), Israel’s 25 IVF clinics
constantly expand their activity (MOH, 2015a). As shown in
Fig. 1, the number of IVF cycles performed annually rose
from 5000 in 1990 to 40,000 in 2012, visibly outpacing the
local population growth.
The steep rise in IVF use in 1996 reflects the fast adoption of
ICSI in Israel, which turned IVF-ICSI into the standard
treatment for male infertility as well. Given the presence of
male factor in roughly half of all infertility cases in Israel
(Berman et al., 2012), the endorsement of ICSI practically
doubled the number of IVF clientele. The expansion continued,
however. Between 2000 and 2012, the rate of treatment cycles
rose by 82.7% (MOH, 2015a). Israeli women are the world’s
greatest consumers of IVF (see Table 1), undergoing twice as
many cycles per capita as Danish women, who are in second
place. Israel’s usage of IVF is over five times the European
average and ten times the international average (Sullivan
et al., 2013).
Accordingly, IVF live births rose from 1.7% of Israel’s total
live births in 1995 to 4.3% in 2013 (Haklai, 2015). The mean
live births per delivery has slightly dropped, from 1.3 to 1.2
from 2003 onward (ibid), reflecting the limited implemen-
tation of the single embryo transfer policy, possibly due to
the relatively advanced age of Israeli IVF users (Israeli
Fertility Association, 2010).
The exceptional usage is linked to the high age limit
(45 years) of eligibility for funded IVF, as reproductively
older women normally require more treatment cycles to
conceive. Indeed, a third of IVF treatments in Israel are
delivered to women above 40 (Sela et al., 2013). Israeli
fertility doctors are well aware of the reduced success rate
of IVF-assisted delivery in advanced age. When asked, they
attribute their practice to women’s insistence, which is
bolstered by the state’s funding policy.
Notably, the potential health risks posed by multiple IVF
cycles are hardly discussed, or systematically researched,
even though Israeli doctors have unique access to the
subject, due to the exceptional local usage. Doctors explain
the research lacunae by the lack of a national IVF registry,
which was founded only in 2012, three decades after the
technology arrived and spread in the country.
Table 1 Prevalence of IVF in selected countries.
Country Population
size (million) a
No. of IVF
cycles b
No. of IVF cycles/
million people
Israel 7.209 38,284 5311
Denmark 5.569 14,578 2618
Australia/NZ 26.909 66,347 2466
Sweden 9.723 18,510 1904
Spain 47.737 66,120 1385
France 66.259 85,433 1289
EU 511.434 588,629 1151
Italy 61.680 63,777 1034
UK 63.742 59,807 938
Germany 80.996 67,596 835
USA 318.892 151,923 476
Russia 142.470 56,253 395
aCIA Factbook (2015b).
bESHRE (2014).
18 D Birenbaum-CarmeliIn 2014, partly in conjunction with the establishment of
the new registry, moderate restrictions were placed on
the provision of IVF (i.e. if no embryo was transferred in four
consecutive cycles, or no conception occurred in eight
cycles, the woman should undergo reassessment before
further treatment). Some politicians protested even against
these lenient limitations as injurious to women and to
Jewish reproduction. The routinization of IVF in Israel
was well captured by an Israeli woman who attributed her
choice to undergo IVF as being ‘the easiest route to
pregnancy’ (Birenbaum-Carmeli and Dirnfeld, 2008).
Israel’s IVF industry has become world famous and as a
result, it attracts international consumers. Some users, primar-
ily Russian clients, seek prestigious IVF services. For them, the
geographical proximity, the relatively affordable prices and the
numerous Russian-speaking professionals – Jewish doctors and
nurses who immigrated to Israel in the 1990s – render Israel the
destination of choice. Other reproductive travellers arrive from
countries where IVF is substantially costlier, such as the USA
(Shamah, 2012). Some of these travellers, although not all, are
Jewish. Occasionally, some Jewish Americans immigrate to
Israel in order to receive state-funded IVF as Israeli citizens.
In an attempt to attract this international clientele, Israeli
clinics, including major medical centres like Hadassah in
Jerusalem, advertise their services in foreign languages.
International brokers entice consumers by using tourism
language: ‘Need IVF? Want to visit Israel? Combine the two
with us’ and suggest ‘the idea that Christians can come and get
healed in the place where Jesus did his healing’ (Shamah,
2012).Globalization: gamete donation
Globalization has great prominence in Israel’s donor gamete
economy. Until the early 1990s, the simple technology
of donor insemination (DI) was informally practised in Israel.
A gynaecologist would synchronize the clinic appointment
of a receiving couple with a donor’s visit, so he could
perform insemination while ensuring that the partiesdidn’t meet (Birenbaum-Carmeli et al., 2000; Carmeli
and Birenbaum-Carmeli, 2000). In 1992, still before ICSI,
when DI was used mainly to overcome male infertility
among heterosexual couples, new MOH regulations con-
fined DI to hospital-based sperm banks and banned the use
of fresh sperm due to HIV risk. The state regulations also
required that prior to DI the doctor established ‘the
woman’s inability to conceive… by her partner’s sperm
exclusively’. The state was thus willing to pay for IVF and
to jeopardize women’s health in order to enhance the
supremacy of biogenetic reproduction over alternatives.
When DI was unavoidable, the regulations sought to feign a
‘natural family’ appearance: the state bestowed the respon-
sibility for donor matching on the doctor alone and enforced
permanent secrecy on the procedure. Moreover, it recom-
mended that whenever possible, the doctor mixed the donor’s
sperm with the husband’s, so as to blur the baby’s genetic
origin (Carmeli and Birenbaum-Carmeli, 2000). Lacking an
alternative solution to male infertility or a source for donor
sperm, and largely sharing the ‘natural family’ ideology,
Israeli recipients, mostly heterosexual couples, complied with
the regulations.
At that time, sperm banking already had an international
component. According to traditional Jewish law, the ‘wasting’
of sperm, even for the purpose of DI, is a sin. Orthodox couples
therefore prefer to use sperm of non-Jewish men, thereby also
removing the concern of future incest. To serve this population,
a peripheral hospital in Israel ran a small sperm bank of
non-Jewish kibbutz volunteers (Kahn, 2000).
Since the introduction of ICSI, heterosexual couples
hardly seek DI. Sperm banks currently serve primarily single
and lesbian women. Incidentally, the change in clientele
coincided with a decline in sperm donors, forcing recipients
to wait long months for suitable sperm (Rosenblum, 2010).
Various explanations may account for the decline in sperm
donors: the relatively modest payment to donors ($80–150
per sample); the fear of upcoming disclosure policy (ibid);
lower willingness to assist single and lesbian women (rather
than infertile men); a State Comptroller report (2006)
that disclosed irregularities in the management of sperm
banks, including allowing over 25 babies per donor (State
Comptroller, 2006). Additionally, foreign kibbutz volunteers
grew rarer, leading to a decline in non-Jewish sperm donors
and closing of the local non-Jewish sperm bank. (Muslim and
Christian Arab men hardly donate sperm in Israel. For
discussions of the prohibition of gamete donation in Sunni
Islam, see Inhorn and Gurtin, this issue.)
Births out of wedlock are rare in Israel (roughly 5%).
However, whether due to growing legitimacy of this parental
formation or further intensification of the maternal imperative
(Donath, 2015), the figure has been increasing consistently
during the last two decades (Central Bureau of Statistics, 2011).
In line with this trend, the demand for donor sperm has also
risen. With the mounting demand and dwindling supply, in the
context of intense globalization, purchasing sperm abroad has
become both necessary and feasible. Israeli women, as well as
Orthodox couples, started to avail themselves of this option. In
response, the MOH issued licences for individual women or
couples to import sperm from spermbanks abroad. This practice
has gradually spread and a substantial portion of donor sperm in
Israel is now imported. Notably, both local and ‘foreign’ sperm
are not state subsidized and prices are constantly increasing. In
19Assisted reproductive technologies in Israel2011, the price of domestic donor sperm had doubled from $100
to $210 per sample. Imported sperm currently varies between
$650 and $1000 (Doron, 2011). Given the average Israeli
monthly salary of $1900 ($2200 for men and $1450 for women;
annual income is $26,000 and $17,400, respectively; Bendlak,
2012), these sums are significant but not unaffordable.
In 2008, years after the routinization of ICSI, which
resolved most male infertility problems and rendered sperm
donation a technology that serves mostly single and lesbian
women, when the field had been thoroughly globalized,
Israel’s MOH removed from its DI regulations the prerequisite
to ‘establish the woman’s inability to conceive by her
partner’s sperm’, which in practice subjected fertile
women to IVF as a condition for DI. It also banned the
mixing of the donor’s sperm with that of the husband. This
revision offers a good illustration of both the state’s power
to channel assisted reproductive technology practice so as to
promote particular interests (e.g. the superiority of bioge-
netic over social kinship) and the capacity of laypersons to
circumvent state diktats in the age of globalization (e.g. by
finding alternative sources abroad). In March 2015 the state
further simplified the importation of sperm, when it licensed
several foreign sperm banks to serve Israelis without the
need for personal approvals (MOH, 2015b).
Egg donation presents a different set of challenges. Until
2010, only women undergoing IVF were allowed to donate eggs
in Israel. Other donations – commercial or altruistic – were
banned. In this context of a shortage of donor eggs, a major
clinical scandal broke out in 2000. A senior fertility expert was
found to have over-medicated patients in order to procure
numerous eggs – asmany as 100 per woman –many of which he
sold to his other patients. The ‘donating’ women were either
partly or completely unaware of the procedure. The exposure
of this malpractice stirred great disquiet, following which
Israeli gynaecologists hardly ever bring up the option of egg
donation. Meanwhile, more and more women of advanced
reproductive age were seeking conception, increasing the
demand for eggs. Seeking eggs abroad has been virtually the
only option for these Israeli women.
Since Jewish identity is inherited matrilineally, the
involvement of non-Jewish egg donors is religiously sensi-
tive. Traditionally the birth mother, namely ‘the womb’,
was considered the defining component (Kahn, 2000). The
ability to separate the womb from the egg has destabilized
this criterion. Some Rabbis contend that only an egg of a
Jewish donor ensures the child’s Jewishness (David, n.d.).
Others adhere to the womb as the decisive factor and apply
the ‘foreign sperm logic’, i.e. preferring eggs of non-Jewish
donors as they remove the concern of future incest (ibid).
The landscape of transnational egg donation reveals that
Israelis endorse both approaches. Some Israelis seek ‘Jewish
eggs’ despite their sky-rocketing prices ($30,000–50,000;
Cain-Nielsen, 2013; Embryon, 2015; NY LifeSpring, 2015;
Or-El, 2010; Ryan, 2012). This practice suggests that ova
donation may enhance the weight of genetic materiality as
a defining factor in contemporary Jewish identity (Nahman,
2006).
Most Israelis opt, however, for ova of non-Jewish donors,
which they obtain via Israeli doctors who run egg donation
clinics abroad, primarily in Eastern Europe (Nahman, 2006,
2011, 2013). Such traffic of ova and women has been in place
for well over a decade and is well established. Notably, in alltransnational donations the foreign donors and the Israeli
recipients remain anonymous to each other. At present,
following several cases in which Israeli practitioners were
suspected of breaching the local law of the ova donors’
country of origin (e.g. Romania), and similar to DI licensing,
the MOH approved certain clinics in Eastern Europe and the
USA to provide donor ova to Israeli recipients (MOH, 2015c).
The source countries for donor eggs are noteworthy, as
Israelis, even those who obtain non-Jewish donor eggs,
apparently attribute social significance to the gametes.
Somewhat similar to the sperm bank director who said he
‘wouldn’t give “Arab sperm” to a Jewish woman’ (Carmeli
and Birenbaum-Carmeli, 2000), most Israeli recipients would
refuse Palestinian ova, although most are happy to accept
‘Romanian eggs’ (Nahman, 2013). The openness to some ova
alongside the rejection of others suggests that the application
of assisted reproductive technologies is greatly influenced by
extra-genetic nationalist notions of ‘chosenness’ (Weiss, 2002)
as well as consumerist, class ideas about white and European
identities (Nahman, 2006). Some recipients possibly take
the use of ‘foreign eggs’ as an opportunity to influence the
child’s appearance, so they look more European or Ashkenazi
(Birenbaum-Carmeli and Carmeli, 2002a, 2002b; Nahman,
2006, 2013; Carmeli et al., 2001). The total disregard of
neighbouring countries like Greece or Turkey as sources for
donor eggs is especially significant, given that about half of
Jewish Israelis are of Middle Eastern descent.
Like donor sperm, donor eggs are not state funded. In the
rare cases where the donation is carried out in Israel, the
payment to the egg donor is $5000. However, as mentioned,
few Israelis step forward as egg donors. Foreign egg
donations reach $7000–8000 per cycle, or $12,000 for a
shared risk cycle, which covers a second cycle if the first one
fails (Hadassah Medical Centre, 2015). Private health
insurances reimburse up to $3000 for all the cycles towards
each of the woman’s first two children (Clalit, 2015). Egg
donation thus requires over half an average annual income,
which renders the treatment inaccessible for many Israelis,
especially for single women, whose income is, as mentioned,
about a third lower than men’s.
Possibly because it entails complex international transac-
tions and potential harm to donors, the regulation of egg
donation has invoked relatively intense reactions among Israeli
feminists (Eyal et al., 2008; Noy et al., 2007). In 2010, following
discussionwith the latter, newMOH regulationswere published,
allowing any healthy, single woman aged 21–35 to donate eggs
up to three times in her life, paying close attention to the
donor’s well-being. The regulations dictate permanent donor–
recipient anonymity. If one of the women is Jewish they also
mandate similarity in religious affiliation, tacitly reasserting the
acuteness of genetic materiality as a constituent of Jewish
identity. As mentioned, the new regulations did not yield the
expected change and Israeli women who need donor ova, and
can afford it, keep travelling abroad.Privatization – surrogacy
The proliferation and globalization of assisted reproductive
technologies was accompanied by extensive privatization of
services. Although renowned for its free IVF policy, Israel’s
assisted reproductive technology sector has seen an
20 D Birenbaum-Carmeliever-growing personal investment. Nowhere is this trend
more prominent than in surrogacy, the most complex and
expensive of assisted reproductive technologies. As will be
shown below, however, financial privatization does not
mean freedom from state inspection or licensing. Rather,
the opposite is true. Surrogacy is tightly controlled by the
state of Israel: domestic surrogacy places every applying
couple under close state scrutiny as a prerequisite to
contract approval; same-sex couples are effectively forced
to look for surrogacy solutions outside the country but even
they must comply with a wide set of state requirements in
order to be granted the right to register their babies as
Israeli citizens. The term ‘privatization’ thus designates in
the present context two principal features: private funding
and private initiative in attending to all surrogacy-related
logistics.
Until the early 1990s, surrogacy was illegal in Israel. In
1991, an Israeli estranged couple, Ruti and Danny
Nahmani, had a fierce legal dispute over the transplanta-
tion of their embryos in an American gestational surro-
gate. Ruti was over 40 and had had her womb removed
due to illness. When she was about to fly to the USA to
have the embryos transplanted, Danny withdrew his
consent as he had formed a new relationship. Ruti sued
Dani and won her case. Danny appealed to the Supreme
Court and won, but then lost again in Ruti’s subsequent
re-appeal to the Supreme Court (Birenbaum-Carmeli,
2007). In 1996, shortly after this perplexing case, Israel
formed its Embryo Carrying Agreement Law, becoming the
world’s first country to regulate surrogacy by means of
dedicated primary law. The swift ratification of the law
suggests the deep disquiet that surrogacy has stirred in
Israel (Teman, 2010). Israel’s law permits only gestational
surrogacy, namely using an egg that is not the surrogate’s.
Moreover, it is available only to stable heterosexual couples.
By restricting access to heteronormative couples, the state
has contained surrogacy within the bounds of traditional
families, thereby largely neutralizing its revolutionary poten-
tial. Like all other forms of assisted reproductive technology,
surrogacy was rapidly endorsed by Israelis. As of 2013, 516
babies had been born in Israel via surrogacy (Hashiloni Dolev,
2013).
Israeli scholars, especially feminists, are divided regard-
ing the surrogacy law. Some criticize the use of the bodies
and lives of surrogates for the benefit of others (Lipkin
and Samama, 2011) while others (Teman, 2010) described
meaningful relations between surrogates and intended
parents. The general public, however, showed no active
interest in the law and accepted it as peacefully as it had
received previous assisted reproductive technology laws and
regulations.
Surrogacy entails extensive financial investment. When
it takes place in Israel, the treatment of the women –
the surrogate and the intended mother – is covered by
the latter’s public health insurance. Additional costs, like
legal advice to the surrogate, insurance and compensation
for her time, suffering and loss of income, are paid by
the commissioning couple. The total sum, exceeding
$40,000 (Pundekaut.com, 2015), equals two average annual
Israeli incomes. Carrying twins or delivering by Caesarean
section entitles the surrogate to additional payment
(Gal, 2008).Cross-border surrogacy, which is the only option available
to single and gay Israelis, is costlier still. (Some heterosexual
couples, who wish to distance the surrogate from their lives,
also turn to cross-border surrogacy.) Gay Israelis often claim
that unlike their counterparts abroad, many of whom reject
the hegemonic idea of the traditional nuclear family,
numerous gay Israelis, mostly couples, are keen to raise
children in a pretty conservative manner. Although data
regarding the relative prevalence of this trend are unavail-
able, the recurrent statements represent a spirit that flows
through Israel’s gay community. In 2012, 255 formal requests
to register children born abroad through surrogacy were
submitted to Israel’s Ministry of Foreign Affairs (State
Comptroller, 2014, 798). These babies are converted to
Judaism shortly after their arrival in Israel. The Israeli
documentary, Google Baby (2012), captures the enormous
investment that Israelis make in such surrogacy procedures
and illustrates the globalized system that they have
developed in their quest for biogenetic parenthood. Having
said that, many gay Israelis declare that they are indifferent
to biogenetic relatedness, claiming they were effectively
forced into surrogacy because no country would place
healthy adoptive newborns with gay couples (Farber, 2014).
Cross-border surrogacy depends entirely on private
initiative and financing. The first Israelis who opted for this
technology, over a decade ago, travelled mostly to the USA.
Paying an American egg donor and an American gestational
surrogate amounted to $150,000–250,000, roughly equal to
8–12 annual average Israeli salaries (2006 figures). Some gay
men, senior professionals in their late 30s or 40s, who are
earning two full male salaries, or those who come from
wealthy supportive families, can embark on such reproduc-
tive journeys. Yet, for many gay Israelis, these sums are
unrealistic.
The popularization of cross-border surrogacy occurred
around 2008, when several agencies started offering surrogacy
services in multiple countries. Donor eggs were purchased
almost invariably from Caucasian women, primarily in Eastern
Europe, theUSA and occasionally in South Africa. Some agencies
also offer donor eggs from non-Caucasian women, e.g. from
India and Nepal. The donor or the embryos are then flown to the
gestational surrogate’s clinic, often located in developing
countries in Asia, depending on legislation and price shifts.
This complex international combination is cheaper than the USA
route, costing around $50,000–60,000. However, even this
reduced price is far beyond reach for many Israelis, gay and
heterosexual alike.
With the proliferation of cross-border surrogacy, some gay
parents decided to try to have twins. This goal certainly
represents an attempt to optimize the high expense. At the
same time, it seems to embody the desire ofmany gay Israelis to
have ‘a full family’ rather than raise a child. Formal data on the
subject is unavailable. Evidently, however, Israeli gay families
often comprise twins and/or siblings.
Beyond the cost, cross-border surrogacy entails a ‘private’
encounter with the state bureaucracy. This encounter is
obstacle-ridden, requiring lawyer services from early pregnancy
until months after the birth. The parents must wait in the birth
country for a court order, followed by tissue typing in a
designated laboratory. Until recently, the partner of the
biological father had to undergo full adoption procedure and
had no custody rights until its completion (Farber, 2014).
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spend long weeks and months in the birth country, often in
inconvenient accommodation, sometimes without proper
health insurance for the newborns, incurring excessive costs.
In the prevalent case of twin births, the babies are especially
likely to require intensive medical care. The procedures further
extend due to bureaucratic delays that prevent the new family
from returning to Israel. Incidental problems like a clerk’s
mistake or a national holiday in either country further prolong
the parents’ imposed stay abroad. Some gay Israelis expressed
great frustration at the state’s alienating approach, which they
criticize in a national-political context:
‘The state treats us and our families as if we were
second-class citizens, as if we were law breakers who took
too much liberty, despite the fact that we are barred from
surrogacy in Israel. For fact, we are not equal citizens like
other Israelis, who don’t have to take a lawyer and go to
court for every trivial issue. Though I and my partner pay our
taxes fully, though I served in a prime military unit, then
studied and today I work and represent my country with
great honor in international conferences abroad, the state
doesn’t represent me properly in whatever relates to my
basic needs. All I ask for is to have a family and be a parent
like any other parent in Israel.’ (Farber, 2014)
From gay men’s accounts, their use of cross-border
surrogacy was not only lacking state support, but was also
actively antagonized by state authorities. The excessive
hardships that users of cross-border surrogacy endure was
formally acknowledged by Israel’s Supreme Court as dis-
criminatory (Supreme Court 2011, 566/11: 1–81).
This description somewhat contradicts the prevalent
image of pronatalist Israel. Whereas the state does allow
domestic surrogacy and accepts cross-border surrogacy,
including for gay men, the state nonetheless conveys a
clear message regarding its reproductive hierarchy: IVF with
the parents’ gametes receives full funding even when the
chance of success is remote; donor gametes are allowed but
not funded and are increasingly outsourced to foreign
countries (the related medical services are publicly funded);
surrogacy is allowed for heterosexual couples subject to the
approval of committee and is extremely costly; gay men
have no option but to go overseas to fend for themselves
when trying to found families. Whereas the reluctance might
be advocated in the name of the human rights of gestational
surrogates, the state-imposed difficulties hardly refer to this
aspect and rather focus on the new families’ relatedness, for
instance, in requiring genetic tests from the parents.
In the past few years, homosexual couples have repeatedly
protested against their exclusion from domestic surrogacy, with
some claiming their right to contact a Jewish surrogate in order
to ensure the child’s Jewishness. In 2010, the MOH responded to
the mounting discontent by convening the Mor-Yosef Commit-
tee to consider surrogacy and assisted reproductive technolo-
gies in general. The committee acknowledged gay men’s
demands, and proposed to entitle single and gay applicants to
domestic surrogacy. If applied, these recommendations would
further expand the scope of surrogacy in Israel and intensify
moral issues regarding the rights of surrogates. At the same
time, it will promote the reproductive rights of gay people.
(Notably, a minority in the committee expressed concern that
the relative financial fortitude of gay couples might push up
surrogacy prices, thereby rendering it inaccessible for thegenerally poorer heterosexual couples for whom the law was
originally devised.)
Meanwhile, minor changes make cross-border surrogacy
somewhat more gay-friendly. As of 2009, gay men are
entitled to maternity benefits and as of March 2015, the
highly complex adoption procedure was replaced by the
simpler and swifter legal procedure that leads to the issuing
of ‘parenting order’.Discussion
The expansion of assisted reproductive technologies in Israel
over the last three decades has reflected and furthered their
normalization. Present-day reproduction in Israel is thor-
oughly technologized, with assisted reproductive technolo-
gies perceived by both professionals and laypersons as
integral to procreation. From pre-conception testing to
pregnancy follow-up, practically all Israeli women subject
themselves to repro-technological monitoring that has
become part and parcel of ‘normal pregnancy’ (Ivry, 2010).
When facing a fertility problem, assisted reproductive
technologies come to the fore. As discussed, Israelis make
use of multiple reproductive technologies, from IVF-ICSI to
gamete donation and surrogacy. Indeed, due to the generous
public funding policy, assisted reproductive technologies are
more accessible in Israel than anywhere else and are within
the reach of wider population segments. Whereas this policy
can – and should – be probed critically, its enabling impact
does allow Israelis, including poorer couples and single
women, to materialize the quest for parenthood, with its
far-reaching personal and social implications in Israel.
Potentially, the sweeping endorsement of assisted repro-
ductive technologies might have distanced conception from
‘nature’ and even erode ‘nature’ as the basis for kinship.
The findings suggest, however, the opposite, that following
the spread of assisted reproductive technologies, notions of
biogenetic relatedness dominate reproduction in Israel. DI
was replaced by ICSI and adoption by egg donation and
surrogacy; a thriving donor-matching industry helps recipi-
ents of donor gametes ‘pass as natural’ and the media
praises women who persist in exceptionally long fertility
treatments. Biological parenthood, previously ‘destiny’, has
been largely reconfigured as ‘accomplishment’, rendering
childlessness and even adoption as nearly a ‘failure’, for
presumably anyone passionate and determined enough can
have their ‘own’ biogenetic offspring. In this social climate,
biological parenthood has become an embodiment of
parents’ desire, resourcefulness and financial fortitude.
The trajectories outlined above – proliferation, globaliza-
tion and privatization – paint a polarized assisted reproductive
technology landscape. On the one hand, the state provides
comprehensive funding for an expanding IVF-ICSI industry,
thereby conveying its strong support of traditional biogenetic
families and constituting such relatedness as a life goal that is
worth ‘fighting’ for. On the other hand, the state leaves Israelis
who require donor gametes or surrogacy (let alone adoption) to
fend for themselves in a globalized, privatized world. Although
the state legally regulates these modes of family formation, it
offers no support to local users who must rely on, and possibly
deplete, their private resources. Israel’s assisted reproductive
technology policy has thus set up a two-tier system wherein
22 D Birenbaum-Carmelibiogenetic relatedness is state-enshrined and privileged while
also requiring massive technological assistance, whereas
‘incomplete’ forms of biogenetic kinning are relegated to
the personal domain where seekers must pursue options by
themselves.
Given the polarized funding policy and the exceptional
usage of all forms of assisted reproductive technologies in
Israel, one wonders whether this assisted reproductive
technology landscape possibly captures broader local
dynamics. Two major trends seem relevant in this context:
the expansion of neoliberalism and rising primordialism. In
the spirit of neoliberal autonomy, Israelis are called to set
their own personal life goals freely. Striving for a bioge-
netic family is widely viewed as a worthy personal goal.
Thus, when Israelis undergo tens of IVF cycles or travel the
world in search of donor gametes or gestational surrogates,
they pursue an autonomous desire for biogenetic related-
ness. Other Israelis – and non-Israelis – may decide to sell
their gametes or carry a surrogate pregnancy. Although all
are governed by state laws, these actors embark on their
quests at their own discretion as well as responsibility and
risk.
This autonomous – or presumably autonomous – personal
quest advances, however, several state interests. Econom-
ically, it generates market activity, stimulating the local
public and private health sectors as well as international
commerce. Demographically, by endorsing the pronatalist
‘imperative’, Israelis contribute, of their own free will, to
enlarging the country’s Jewish population. Although IVF-ICSI
is available to all Israelis, including non-Jewish citizens, with
growing globalization and privatization, assisted reproduc-
tive technology conception becomes increasingly stratified
and accessible to wealthier sectors that consist, primarily,
of Jewish Israelis.
A probably more foundational contribution of Israel’s
two-tier assisted reproductive technology policy is, however,
to its regional politics. It is in this sphere that the intensifying
primordialism comes into play. Zionism, since its early days,
constituted the biological as a symbolic currency for grounding
claims about collective Jewish genealogies and concomitant
national rights (Falk, 2006a, 2006b; Hirsch, 2009). The emphasis
on biogenetic relatedness highlights the primordial aspect in
individual families as well as in the Jewish collectivity. Assisted
reproductive technologies,which enable novel forms of kinning,
destabilize traditional notions of biogenetic relatedness. As
such, they pose a threat to the ‘naturalness’ of genealogy and
hence, of the Jewish collectivity as primordial. If notions of
biological relatedness indeed resonate with and indirectly
advance Israel’s political claims, including the claim to the
‘land of our forefathers’, a proactive state effort to sustain this
crucial idiom of relatedness seems plausible. The toll that this
assisted reproductive technology policy takes from Israelis –
women who undergo tens of treatment cycles and seekers of
less traditional kinning who receive no state support –might be
viewed as an aspect of the liberty that the state can take when
it defines an issue as the protection of life itself. In a neoliberal
reality, this toll may sometimes be largely self-inflicted.
From this perspective, Israel’s polarized assisted repro-
ductive technology policy, which reaffirms the priority
of biogenetic relatedness over social kinning, enhances
the centrality of the former as a constituent of Jewish
collectivity. This interpretation helps elucidate the vaststate investment in assisted reproductive technologies that
can now be understood as an element in the state’s broader
national project.References
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